While the intense focus in Congress last week was the passage of the American Healthcare Act, millions of Americans continue to struggle with the cost of prescription medications. In 2016, 45 million Americans did not fill a prescription because of cost, and a recent poll commissioned by Prescription Justice shows that 75% Americans agree with President Trump that they drug companies are getting away with murder.
Not just individual patients but federal and state governments face an uphill budget battle as well. Public programs like Medicare, Medicaid and the Department of Veteran's Affairs continue to grapple with dramatic price increases that are crippling their budgets.
Congress has introduced several bills in 2017 to address the crisis of high drug prices. Here’s a summary:
Improving Access to Affordable Prescription Drugs Act (HR 1776/S. 771)
On March 29, S. 771, The Improving Access to Affordable Prescription Drugs Act (Act), was introduced by Senator Al Franken (D-MN) and fifteen Democratic co-sponsors. A companion bill (HR 1776) was also introduced in the House by Representative Jan Schakowsky (D-IL) with four Democratic co-sponsors.
We are proud to announce that we have changed our organization's (DBA) name from Prescription Justice Action Group to Prescription Justice, which is a simpler expression of our core position: making prescription drugs affordable is an issue of justice for Americans and we will help them obtain it.
In addition to our website and logo redesign, we have also added a weekly media update that features top news and journal articles focused on our policy priorities - personal drug importation, Medicare Drug Price Negotiations, and ending "Pay for Delay", - as well as other advocacy efforts about tackling the prescription drug price crisis in America and globally.
Let's all work together to bring about prescription justice!
Last week, Senators Bernie Sanders (I-VT) and Amy Klobuchar (D-MN) proposed an amendment (S.A. 178) to the Senate Budget Reconciliation bill that would allow individuals, pharmacies and wholesalers to import prescription medications from Canada and other countries with a valid prescription from a U.S. provider.
The amendment took place during a 7-hour vote-a-rama in which more than 150 amendments were considered and voted on for a brief ten minutes.The amendment failed 52-46, with 13 Democrats voting against it. While the measure failed to pass, it surprisingly garnered support from 12 Republicans including Senators Ted Cruz and Rand Paul. It’s worth noting that Senators Chuck Schumer (D-NY) and Kristen Gillibrand (D-NY) voted against the Dorgan-Snowe importation amendment in 2009, voted yes this time around. (more…)
Last year, U.S. spending on prescription drugs was at a record breaking $425 billion before discounts, and is expected to rise by 22% annually over the next five years, which is 400%, or over $600 billion by 2020. As Donald Trump is sworn in as the 45th president of the United States, Americans across the country concerned with the soaring costs of prescription medications, will be looking to President Trump and Congress for solutions to address this national crisis.
President-Elect Trump’s top priority for healthcare reform is to repeal the Affordable Care Act, but most Americans are more concerned about prescription drug prices than Obamacare. A recent Kaiser Health Tracking Poll found that nearly 74 percent of Americans agree that a top priority for the next president and Congress should be to ensure that drugs for chronic health conditions are affordable for patients. Additionally, 63 percent believe that the federal government’s top priority should be to lower the cost of prescription medications. Last week, President-Elect Trump released a brief healthcare plan on his transition website. While the newest healthcare plan does not include prescription drug pricing, during the campaign Mr. Trump declared support for allowing Americans to import lower cost medications as part of his 7-point healthcare plan. Although not noted on that plan, President-Elect Trump voiced support for Medicare drug price negotiations during his campaign.
Part of a series of posts about common chronic illnesses and what happens when people cannot afford prescription medications to treat them.
Americans are dying from cancer because they either can’t afford the medications to treat it, or they have the money but refuse to bankrupt their families. Cancer is the second leading cause of death after heart disease in the U.S., claiming more than half a million lives each year. In 2016, it is estimated that 1,685,210 new cases of cancer will be diagnosed in the U.S., amounting to one new diagnosis every 30 seconds.